ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Product Shipments and Accounts Receivable, By Distributor (Details)
|
12 Months Ended |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Customer concentration risk | Consolidated revenue |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
100.00%
|
100.00%
|
| Credit concentration risk | Accounts receivable related to product sales |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
100.00%
|
100.00%
|
| Cardinal Health | Customer concentration risk | Consolidated revenue |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
34.00%
|
42.00%
|
| Cardinal Health | Credit concentration risk | Accounts receivable related to product sales |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
44.00%
|
53.00%
|
| McKesson Corporation | Customer concentration risk | Consolidated revenue |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
24.00%
|
14.00%
|
| McKesson Corporation | Credit concentration risk | Accounts receivable related to product sales |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
23.00%
|
20.00%
|
| AmerisourceBergen Corporation | Customer concentration risk | Consolidated revenue |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
26.00%
|
13.00%
|
| AmerisourceBergen Corporation | Credit concentration risk | Accounts receivable related to product sales |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
29.00%
|
18.00%
|
| Collegium | Customer concentration risk | Consolidated revenue |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
0.00%
|
11.00%
|
| Collegium | Credit concentration risk | Accounts receivable related to product sales |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
0.00%
|
0.00%
|
| All others | Customer concentration risk | Consolidated revenue |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
16.00%
|
20.00%
|
| All others | Credit concentration risk | Accounts receivable related to product sales |
|
|
| Concentration Risk [Line Items] |
|
|
| Total |
4.00%
|
9.00%
|